| Literature DB >> 24879612 |
Jiří Václavík1, Petr Sot1, Jan Pecháček1, Beáta Vilhanová1, Ondřej Matuška1, Marek Kuzma2, Petr Kačer3.
Abstract
The asymmetric transfer hydrogenation (ATH) ofEntities:
Mesh:
Substances:
Year: 2014 PMID: 24879612 PMCID: PMC6272002 DOI: 10.3390/molecules19066987
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1Typical routes towards the preparation of 1,2,3,4-tetrahydroisoquinolines (THIQs). Route I proceeds via the Schotten-Baumann acylation of the starting amine, Bischler-Napieralski cyclization of the resulting amide, and reduction of the C=N bond. Route II comprises the formation of an imine which subsequently undergoes the Pictet-Spengler reaction. The steps in which asymmetry originates are marked with asterisks.
Figure 1Selected structures of N-aryl and N-alkylsulfonyl-DPEN ligands that have been reported.
Figure 2(a) Interaction of the sulfonyl group with protonated DHIQ via a hydrogen bond (green dashed line). (b) Interaction of the sulfonyl group with protonated amines viahydrogen bonds (green dashed line).
Figure 3A section of a 1H-15N gHMBC NMR spectrum of a mixture of catalyst [RuCl(η6-p-cymene)TsDPEN], HCOOH, piperidine-15N and acetonitrile-d3[36].
Single-point energies and Gibbs free energies of the hydrogen bond between catalyst and protonated amine molecules [38].
| Entry | Solvation | Amine | Δ | Δ | Δ |
|---|---|---|---|---|---|
| 1 | none | –220.0 | –234.6 | –177.6 | |
| 2 | none | Piperidine | –208.4 | –222.0 | –166.2 |
| 3 | none | Piperidine | –204.0 | –210.7 | –159.1 |
| 4 | none | Triethylamine | –203.1 | –210.0 | –157.3 |
| 5 | none | Tributylamine | –206.8 | –210.3 | –158.4 |
| 6 | IEFPCM | –76.2 | –81.4 | –24.1 | |
| 7 | IEFPCM | Piperidine | –79.6 | –81.5 | –25.9 |
| 8 | IEFPCM | Piperidine | –78.2 | –77.2 | –26.7 |
| 9 | IEFPCM | Triethylamine | –89.4 | –87.3 | –31.0 |
| 10 | IEFPCM | Tributylamine | –95.5 | –93.5 | –46.5 |
ATH of 1-methyl-3,4-DHIQ with [RuCl(η6-p-cymene)(S,S)-TsDPEN] and HCOOH/amine (5/2) hydrogen-donor mixtures [a].
| Entry | Amine | Initial reaction rate [mmol∙min−1∙mmolcat−1] | |
|---|---|---|---|
| 1 | 1.73 | 85 | |
| 2 | Piperidine | 2.75 | 85 |
| 3 | Triethylamine | 2.86 | 83 |
| 4 | Tributylamine | 2.55 | 84 |
[a] Initial reaction rates were calculated from the linear part of each conversion curve by the least-squares linear regression method. The reaction conditions were adapted from our previous study [44]. [b] The ee values were determined by employing a GC method reported by us [45].
Figure 4Transition state of hydrogenation of 1-methyl-DHIQ with [RuH(η6-p-cymene)(R,R)-TsDPEN] with Et3NH+ hydrogen-bonded to one oxygen atom of the sulfonyl group (optimized geometry).
Figure 5Transition state of hydrogenation of 1-methyl-3,4-DHIQ with [RuH(η6-mesitylene)TsDPEN] featuring double CH/π interaction.
Figure 6General structures of common imine substrates.
Figure 7Transition state of hydrogenation of 1-phenyl-DHIQ with [RuH(η6-mesitylene)(S,S)-TsDPEN] optimized at the ωB97XD/Def2-SVP level [38].
Calculated interatomic distances for the proton located between the nitrogen of the imine substrate and oxygen of the formate anion [38] [a].
| 1-Me | 6-MeO-1-Me | 7-MeO-1-Me | 6,7-diMeO-1-Me | 1-Ph | |
|---|---|---|---|---|---|
| N–H [Å] | 1.5196 | 1.0675 | 1.0763 | 1.0702 | 1.5677 |
| H–O [Å] | 1.0522 | 1.5868 | 1.5556 | 1.5764 | 1.0416 |
| C=N [Å] [a] | 1.2785 | 1.2799 | 1.2784 | 1.2788 | 1.2795 |
| C=N [Å] [b] | 1.2825 | 1.2943 | 1.2900 | 1.2929 | 1.2828 |
| C=N+ [Å] [c] | 1.2977 | 1.3026 | 1.2978 | 1.3020 | 1.3020 |
| Activation [%] [d] | 21.3 | 63.4 | 59.8 | 60.8 | 14.7 |
[a] DHIQ without formic acid. [b] DHIQ forming an associate with formic acid. [c] Fully protonated DHIQ (anion omitted). [d] Activation was calculated by comparing the C=N bond length difference (between neutral DHIQ and DHIQ interacting with formate) with the difference between neutral DHIQ and theoretical maximal activation represented by protonated DHIQ (without the counter-anion).
Scheme 2Tautomerization of DHIQs.
Scheme 3Isomerization of acetophenone N-benzylimine.